1. Home
  2. Southern Africa
  3. South Africa
  • News

Poor turnout hampers HIV vaccine trials

The low turnout of respondents for South Africa's HIV vaccine trials is threatening to undermine research efforts launched almost a year ago. According to researchers from the Medical Research Council (MRC), the fear of AIDS-related stigma and discrimination from communities had prevented people from taking part. Despite ongoing education campaigns, misconceptions about the trials presented another obstacle, as a large number of people believed they could be infected with the HI virus by being inoculated with a test vaccine. MRC senior clinical research nurse Armstrong Makhofola told the UN news service, PlusNews, that such fears were unfounded, "as no live viruses are injected ... the replicating parts of the virus are removed, so that the virus is like a car without a motor."

This article was produced by IRIN News while it was part of the United Nations Office for the Coordination of Humanitarian Affairs. Please send queries on copyright or liability to the UN. For more information: https://shop.un.org/rights-permissions

Share this article

Get the day’s top headlines in your inbox every morning

Starting at just $5 a month, you can become a member of The New Humanitarian and receive our premium newsletter, DAWNS Digest.

DAWNS Digest has been the trusted essential morning read for global aid and foreign policy professionals for more than 10 years.

Government, media, global governance organisations, NGOs, academics, and more subscribe to DAWNS to receive the day’s top global headlines of news and analysis in their inboxes every weekday morning.

It’s the perfect way to start your day.

Become a member of The New Humanitarian today and you’ll automatically be subscribed to DAWNS Digest – free of charge.

Become a member of The New Humanitarian

Support our journalism and become more involved in our community. Help us deliver informative, accessible, independent journalism that you can trust and provides accountability to the millions of people affected by crises worldwide.

Join